~~<i id='0F1FC4FADD'><strike id='0F1FC4FADD'><tt id='0F1FC4FADD'><pre id='0F1FC4FADD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：fashion 2025-09-27 19:29:01 - browse：6

Elite athletes really are different from you and me. Or, at least their gut microbes are.

Scientists who analyzed stool samples of 15 runners a week before and after they competed in the 2015 Boston Marathon found unusually high levels of one particular microbe compared to 10 non-athletes. Levels of the microbe in question, Veillonella, spiked after an intense workout and bloomed even more after the marathon.

That was a lightbulb moment for the scientists because the bacterium is known for breaking down and eating lactate, a metabolite even ordinary runners equate with fatigue.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Colonoscopy at 40? Study finds a possible benefit

focus

hotspot

explore

entertainment

focus

AdobeWASHINGTON—TherearethreeFDA-approveddrugsfortreatingalcoholusedisorder.Butadifferentmedication,

WSS

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Scrutiny of post

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Making the case for fair compensation in clinical trials

Investigation reveals sickle cell patients pressured into sterilizations

3 hurdles to bringing medical devices to the U.S. market

focus

leisure time

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Scrutiny of post

As demand for Covid shots wanes, Moderna seeks its next success

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Cancer drug shortages should be causing more outrage

STAT's guide to the next generation of CAR

Affirmative action in medical school literally saved lives

As a primary care physician, here's how I hope to partner with AI

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

With FDA staff opposed to Sarepta therapy, top official intervened

hotspot

With FDA staff opposed to Sarepta therapy, top official intervened

The strategy behind pharma's lawsuits over drug pricing reform

CDC concerned about possible undetected monkeypox spread in U.K.

#NeedHerScience: shining a light on gender disparities in medicine

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

ASCO eve: Let’s set the table for this year's meeting

hotspot

explore

entertainment

focus